ArrowMark Colorado Holdings LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 135 filers reported holding ENDOLOGIX INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
ArrowMark Colorado Holdings LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$7,430,000
-62.1%
10,376,633
+1.0%
0.08%
-52.4%
Q3 2018$19,627,000
-65.0%
10,276,145
+3.7%
0.16%
-68.2%
Q2 2018$56,112,000
+34.2%
9,913,697
+0.3%
0.52%
+23.2%
Q1 2018$41,812,000
-21.0%
9,884,691
-0.1%
0.42%
-22.0%
Q4 2017$52,912,000
+34.1%
9,890,106
+11.8%
0.54%
+19.6%
Q3 2017$39,454,000
+6.3%
8,846,120
+15.8%
0.45%
-2.6%
Q2 2017$37,126,000
-28.0%
7,639,140
+7.3%
0.46%
-34.6%
Q1 2017$51,546,000
+38.8%
7,119,669
+9.7%
0.70%
+19.8%
Q4 2016$37,132,000
-46.8%
6,491,647
+19.0%
0.59%
-53.8%
Q3 2016$69,833,000
+19.6%
5,455,672
+16.4%
1.27%
+7.4%
Q2 2016$58,388,000
+45.6%
4,686,039
-2.3%
1.18%
+32.8%
Q1 2016$40,091,000
+14.6%
4,795,590
+35.7%
0.89%
-6.9%
Q4 2015$34,994,000
-1.2%
3,534,787
+22.3%
0.96%
-1.1%
Q3 2015$35,426,000
-33.3%
2,889,546
-16.6%
0.97%
-25.3%
Q2 2015$53,150,000
-1.2%
3,464,775
+10.0%
1.30%
-7.1%
Q1 2015$53,775,000
+23.2%
3,150,275
+10.4%
1.39%
+24.2%
Q4 2014$43,641,000
+54.2%
2,854,211
+6.9%
1.12%
+44.6%
Q3 2014$28,298,000
-26.2%
2,669,602
+5.9%
0.78%
-29.1%
Q2 2014$38,360,000
+124.1%
2,522,046
+89.7%
1.09%
+96.8%
Q1 2014$17,114,000
-23.7%
1,329,725
+3.4%
0.56%
-20.2%
Q4 2013$22,429,000
-4.0%
1,286,044
-11.2%
0.70%
-9.4%
Q3 2013$23,373,000
+3159.8%
1,448,149
+2581.8%
0.77%
+298.4%
Q2 2013$717,00054,0000.19%
Other shareholders
ENDOLOGIX INC shareholders Q3 2013
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,000,000$68,280,0009.00%
Essex Woodlands Management, Inc. 1,257,468$26,843,0005.32%
First Light Asset Management, LLC 277,264$4,733,0002.42%
Lisanti Capital Growth, LLC 175,060$2,988,0001.70%
ArrowMark Colorado Holdings LLC 3,150,275$53,775,0001.39%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,349,351$40,103,0001.30%
Rail-Splitter Capital Management, LLC 186,076$3,176,0000.97%
WASHINGTON CAPITAL MANAGEMENT, INC 82,316$1,405,0000.81%
Perceptive Advisors 565,000$9,645,0000.75%
PALISADE CAPITAL MANAGEMENT, LP 1,629,329$27,813,0000.70%
View complete list of ENDOLOGIX INC shareholders